Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jyoti D. Patel
Is Immune Checkpoint Inhibition Part of Standard Therapy for Stage III Non-Small Cell Lung Cancer?
Cancer
Cancer Research
Oncology
Related publications
Immune Checkpoint Modulation for Non-Small Cell Lung Cancer
Clinical Cancer Research
Cancer Research
Oncology
Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer
Cancer
Cancer Research
Oncology
Neoadjuvant Chemoradiotherapy for Stage III Non-Small Cell Lung Cancer
Frontiers in Oncology
Cancer Research
Oncology
Immune-Checkpoint Inhibitor Treatment of Non-Small Cell Lung Cancer Patients
Jurnal Respirasi
Advances in Immune Therapy for Non Small Cell Lung Cancer
Medical Diagnosis
Patterns of Care for Stage III Non-Small Cell Lung Cancer in Australia
Asia-Pacific Journal of Clinical Oncology
Medicine
Oncology
The Predictive Value of Tumor Mutation Burden for Immune Checkpoint Inhibitors Therapy in Non-Small Cell Lung Cancer Is Affected by Patients’ Age
Biomarker Research
Biochemistry
Molecular Medicine
Clinical Biochemistry
Prognostic Value of Neutrophil-To-Lymphocyte Ratio Following Chemoradiation Therapy for Stage III Non–small Cell Lung Cancer
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Is Smoking History the Truly Best Biomarker for Immune Checkpoint Inhibitor Treatment in Advanced Non-Small Cell Lung Cancer?
ESMO Open
Cancer Research
Oncology